Remove Angina Remove Cardiogenic Shock Remove TAVR
article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24 24 and how those may impact clinical practice and patient care in this deep dive clinical trial session.

article thumbnail

American College of Cardiology (ACC24) Show Preview: Advancing Cardiovascular Care for All

DAIC

SHASTA-2—looks at a new medicine plozasiran on the treatment of hypertriglyceridemia SMART Trial—a head-to-head trial of the self-expanding vs. a balloon-expanding TAVR DanGer Shock—brings equipoise to how cardiogenic shock is treated in general, looking at the use of a transvalvular mico-axial flow pump in patients who have infarct or heart attack (..)